Randomized trial of unilateral versus bilateral percutaneous tibial nerve stimulation for the treatment of overactive bladder
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-06107-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Urology, 2025. Verfasst von Gnankang Sarah Napoé und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh…. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Tibial Nerve, Transcutaneous Electric Nerve Stimulation. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Laborie.
Abstract (Originalsprache)
PURPOSE: Optimizing overactive bladder (OAB) management has the potential to improve quality of life. We sought to determine whether bilateral was more effective than unilateral Percutaneuous Tibial Nerve Stimulation (PTNS) at improving OAB symptoms. METHODS: Participants were randomized to either bilateral or unilateral PTNS and followed for 12 weeks. OAB questionnaire short form (OABqSF) and Incontinence Impact questionnaire (IIQ) were administered at baseline and every 4 weeks through week 12. Participants also completed a 2-day voiding diary weekly. Our primary outcome was change in OABqSF from baseline to completion of study. Secondary outcomes included change in IIQ, number of daily voids, nocturia and incontinence episodes. Score changes were compared using ANOVA and pairwise t-test. RESULTS: We randomized 36 women, mean age 68.7 (range 32-90) years. Overall, baseline OABqSF and IIQ scores were similar between the groups. Both groups showed significant improvement in OABqSF over time. 55.6% of participants in the unilateral group and 66.7% of participants in the bilateral group had improvement per OABqSF scores. While both groups showed improvement in IIQ, only the bilateral group's improvement was statistically significant. Although, the mean and median differences in OABqSF, IIQ, and incontinence episodes were lower in the bilateral group, the difference between the groups was not significant. CONCLUSION: Both unilateral and bilateral PTNS led to significant decreases in OABqSF with a trend for more improvement in the bilateral group. IIQ score only improved in the bilateral group suggesting a potential benefit from bilateral use. TRIAL REGISTRATION: The trial was registered on clinicaltrials.gov, NCT03535857.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. sarahnapoe@pitt.edu.
- Magee-Womens Research Institute, Pittsburgh, PA, USA. sarahnapoe@pitt.edu.
- Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA, USA.
- Magee-Womens Research Institute, Pittsburgh, PA, USA.
- Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Brown University, Providence, RI, USA.
Förderung
- Laborie
Zitieren
APA
Napoé, G. S., Hall, E., Dasgupta, P., Myers, D. L., & Wohlrab, K. J. (2025). Randomized trial of unilateral versus bilateral percutaneous tibial nerve stimulation for the treatment of overactive bladder. World Journal of Urology. https://doi.org/10.1007/s00345-025-06107-0
Vancouver
Napoé GS, Hall E, Dasgupta P, Myers DL, Wohlrab KJ. Randomized trial of unilateral versus bilateral percutaneous tibial nerve stimulation for the treatment of overactive bladder. World Journal of Urology. 2025. doi:10.1007/s00345-025-06107-0
BibTeX
@article{Napo2025,
author = {Napoé, Gnankang Sarah and Hall, Evelyn and Dasgupta, Pritika and Myers, Deborah L and Wohlrab, Kyle J},
title = {Randomized trial of unilateral versus bilateral percutaneous tibial nerve stimulation for the treatment of overactive bladder},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-06107-0}
}
EUVIMED